OClawVPS.com
Legend Capital
Edit

Legend Capital

https://www.legendcapital.com.cn/
Last activity: 27.02.2026
Active
Categories: B2CDevelopmentEnterpriseFinTechHealthTechITManufacturingServiceTechnology
君联资本成立于2001年4月,是中国领先的、专注于早期创业投资以及成长期私募股权投资的专业投资机构。在二十多年的发展历程中,君联遵循国际通行标准,经历了多支基金的完整管理周期,创造了优秀且可持续的基金业绩。
Mentions
37
Location: China

Investors 1

Mentions in press and media 37

DateTitleDescription
27.02.2026VITURE Secures $200M, Dominates XR Market, Pushing Spatial Computing ForwardVITURE secures another $100M, reaching $200M in six months. This significant funding reinforces its XR/AR hardware leadership. Capital will propel next-gen product development, global market expansion, and crucial ecosystem collaborations. ...
26.02.2026VITURE Starts 2026 Strong with Another $100M Raise, Surpassing $200M in Six MonthsSAN FRANCISCO, Feb. 26, 2026 /PRNewswire/ -- Following its $100 million raise last September, VITURE has officially closed another $100 million financing round, bringing total capital raised within six months to over $200 million. The lates...
26.02.2026VITURE: $100 Million Raised While Surpassing $200 Million In Six Months To Advance XR And AR LeadershipVITURE announced it has closed a $100 million financing round, bringing its total capital raised over the past six months to more than $200 million. The new round follows a $100 million raise completed in September and underscores continued...
14.01.2026China Deal Review: Market rebound drives startup funding to $5.5b in Dec-
18.12.2025Allink Biotherapeutics Secures $47 Million, Propels Next-Gen Cancer and Immunology TherapiesAllink Biotherapeutics raised $47 million in Series A extension funding. This capital accelerates two critical antibody-drug conjugate (ADC) programs, ALK201 and ALK202, into global Phase I clinical trials. The biotech also expands its mult...
16.12.2025Allink Biotherapeutics Completes $47M Extension Rounds of Series A to Accelerate Clinical Programs and Novel Platforms DevelopmentThe company secured $47 million through extension rounds of Series A led by Legend Capital and Meituan Long-Z Investment with strong backing from both new investors and existing supporters Proceeds to advance two differentiated and highly c...
16.12.2025Allink Biotherapeutics: $47 Million Series A Extension Raised To Advance Two ADC Programs And Expand Multispecific PlatformsAllink Biotherapeutics, a Shanghai-based clinical-stage biotechnology company developing antibody drug conjugates and multi-specific antibody therapeutics for oncology and immunology, has completed extension rounds of its Series A financing...
25.10.2025Neolix: Over $600 Million Series D Funding Raised To Advance China’s Autonomous Driving IndustryNeolix, the world’s largest provider of Level 4 (L4) autonomous delivery vehicles, has completed a record-breaking $600 million Series D funding round, the most significant private financing in the history of China’s autonomous driving sect...
24.10.2025Neolix Secures Record $600M Funding, Drives Global Autonomous Delivery FutureNeolix secured over $600M in record Series D funding, dominating China's autonomous delivery sector. This L4 RoboVan leader holds over 60% market share. Its advanced AI, including map-free navigation and vision-action models, redefines logi...
24.10.2025Neolix Raises US$600+ Million in Series D, Setting New Record for China's Autonomous Driving IndustryBEIJING, Oct. 24, 2025 /PRNewswire/ -- Neolix, the world's largest provider of L4 autonomous delivery (RoboVan) solutions, has raised over US$600 million in its Series D financing. This round marks the largest private fundraising in China's...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In